secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncorus, Inc. (—)
CIK:        0001671818
Form:       8-K
Filed at:   2023-05-05T23:59:59+00:00
Accession:  0000950170-23-018381
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Oncorus gets 180-day Nasdaq extension; stock moves to Capital Market
--------------------------------------------------------------------

- Nasdaq granted extension until October 30, 2023 to meet $1.00 minimum bid price rule.
- Oncorus common stock transferred from Nasdaq Global Market to Capital Market effective May 3, 2023.
- To regain compliance, closing bid price must be $1.00+ for 10 consecutive business days.
- Company may consider reverse stock split; failure could lead to delisting and appeal process.
- CEO Ted Ashburn signed the filing; no assurance of regaining compliance stated.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671818/000095017023018381/0000950170-23-018381-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671818/000095017023018381/oncr-20230502.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-018381

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer